Impact of Yoyo bitters® on the Pharmacokinetic Profile of Ciprofloxacin in Healthy Nigerian Volunteers
doi.org/10.26538/tjnpr/v2i10.4
Keywords:
Ciprofloxacin,, Drug-Herb interaction,, Pharmacokinetics,, Yoyo bitters®Abstract
Ciprofloxacin and Yoyo bitters® (a liquid herbal oral preparation) are readily and widely available as prescription drug and herbal medicine, respectively in Nigeria. They are taken separately or concomitantly. The high metal content of Yoyo bitters poses to be a potential problem for the bioavailability of fluoroquinolones. Thus, this study was carried out to investigate the possible
drug-herb interaction between Ciprofloxacin tablet and Yoyo bitters when co-administered. Pharmacokinetics of oral single dose ciprofloxacin (500 mg) tablet was evaluated in 30 healthy volunteers. The study design was an open, single dose randomized two-way comparative crossover treatment groups. Each group either took ciprofloxacin (500 mg) tablet with 200 mL of water or ciprofloxacin with 30 mL of yoyo bitters. A wash out period of two weeks was observed, and the treatment groups were interchanged. Blood samples were collected and analyzed for ciprofloxacin in plasma using a modified High-Performance Liquid Chromatographic (HPLC)
method with UV detector at 278nm. Non-compartmental analysis was employed for pharmacokinetic parameters estimation. Results indicated that Yoyo bitters altered the Pharmacokinetics of ciprofloxacin (Cmax, AUC, Vd, Tmax, t1/2, Kel and Kab) when administered
concomitantly, although not statistically significant (p>0.05). Therefore, for the desired therapeutic effect of ciprofloxacin to be optimally achieved, concomitant administration with Yoyo bitters or any herbal preparation should be staggered.
References
Miller LG, Hume A, Harris IM, Jackson EA, Kanmaz TJ, Caulfield JS, Knell M. White paper on Herbal Products. Ame Coll Clin Pharm Pharmacother. 1994; 20:877-891.
Oshikoya KM, Senbanjo IO, Njokama OF, Sope A. Use of Complementary and Alternative Medicines for Children with Chronic Health conditions in Lagos, Nigeria. BMC Comp Alt Med. 2008; 8: 66-73.
Catherine CC and Thomas NW. Use of herbal medicine among consultation-liaison population: A review of current information regarding risks, interactions and efficacy. Psychosom. 1998; 39:3-13.
Izzo AA and Ernst E. lnteraction between herbal medicine and prescribed drugs. A systemic review. Drugs 2001;61:163-175.
Janknegt R. Drug Interactions with Quinolones. J Antimicrob Chemother. 1990; 26:7-29.
Hu Z, Yang X, Ho PLC, Chan SY, Duan W, Zhou S. Herb –Drug Interactions. Drugs 2005; 65(9):1239-1282.
Gootz TD, Larrenll JF, Suteliffe JA. Inhibitory Effects of Quinolone Antibacterial Agents on Eukaryotic Topoisomerases and related Test systems. Antimicrob agents Chemother. 1990; 34(1):8-16.
Neumann M. Clinical Pharmacokinetics of the newer antibacterial 4-quinolones. Clin Pharmacokinet. 1988;14:96-121.
Campoli-Richards DM, Monk JP, Price A. Ciprofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1998; 35:373-447.
Neuhofel AL, Wilton JH, Victory JM. Lack of bioequivalence of Ciprofloxacin when administered with calcium-fortified orange juice; a new twist on an old interaction. J Clin Pharmacol. 2002; 42:461-466.
Akinleye MO, HAB Coker, Chukwuani CM, Adeoye AW. Effect of 5-alive juice on the dissolution and absorption profile of Ciprofloxacin. Nig Qtr. J Hosp Med. 2007;17(1):53-57.
Davey PG. Overview of drug interactions with the quinolones. J Antimicrob Chemother 1988; 22(suppl.c):97-107.
Campbell NR and Hasinoff BB. A common cause of drug interactions. Br J Clin Pharmacol 1991; 31:251-255.
Neuhofel AL, Wilton JH, Victory JM. Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction. J Clin Pharmacol. 2002; 42:461-466.
Eboka CJ and Okeri HA. Aqueous solubility of ciprofloxacin in the presence of metal cations. Trop J Pharm Res. 2005;4:349-354.
Urbaniak B, Mrestani Y, Kokot ZJ, Neubert RH. Investigation of interaction of fluoroquinolone with aluminum, iron and magnesium ions using capillary zones electrophoresis. Chromatographia 2007; 65(7-8):489-492.
Martins E, Odusoga AO, Adesina OO, Adewale GB, Kolawole SO. Toxicity evaluation of Yoyo cleanser bitters and Field Swedish bitters Herbal Preparations following subchronic administration in rats. Am Journal Pharmacol Tox 2010; 5(4):159-164.
Zhu M, Wong PYK, Li RC. Influence of Sanguisoba Officinalis, a mineral rich plant drug in rat. J Antimicrobial Chemother. 1999; 44:125-128.
Li RC, Wong PYK, Zhu M. Effect of Taraxacum mongolicum on the bioavailability and disposition of Ciprofloxacin in rats. J Pharm Sci. 1999; 88(6):632-634.
Fugh-Berman A, Ernest E. Herb-drug interactions: Review and assessment of Report Reliability. Br J Clin Pharmacol.2001; 52(5):587-595.
Fugh-Berman A. Herb-drug interactions. The Lancet 2003; 355(9198):134-138.
Wanzala W, Zessin KH, Kyule NM, Baumann MPO, Mathias E, Hassanali A. Ethno veterinary medicine: a critical review of its evolution, perception, understanding and the way forward. Livestock Res Rur Dev. 2005; 17(11):665-672.
Kolawole JA, Kumdi BV, Apeh E. The effect of Yoyo bitters on the Pharmacokinetics of single oral dose Paracetamol tablet in human volunteers. Int J Biol Chem Sci. 2011; 5(2):717-723.
Harvey DT. Modern Analytical Chemistry (1st ed.) USA:The Mc Graw-Hill Company; 2000. 412-421 p.
Adepoju-Bello AA, Issa OA, Oguntibeju OO, Ayoola GA, Adejumo OO. Analysis of some selected toxic metals in registered herbal products manufactured in Nigeria. Afr JBiotechnol. 2012; 11(26):6918-6922.
Norman MA and Hussein OK. HPLC Assay with UV detector for the determination of Ciprofloxacin in human plasma. Greener journal of physical science. 2002; 2(1):20-26.
USP Pharmacopeia, USP 36NF31. 2013; Vol 2: 3000-3001
Gibaldi M and Perrier D. Pharmacokinetics. (2nd ed.). New York: Marcel-Dekker; 1982. 409-417 p.
Li RC, Nix DE, Schentag JJ. Interaction between Ciprofloxacin and metalcations. Its influence on physiochemical characteristics and antibacterial activity. Pharma Res. 1994; 11:917-920.
Lehto P, Kivisto KT, Neuvonen PJ. The effect of ferrous sulphate on the absorption of Norfloxacin, Ciprofloxacin and Ofloxacin. Br J Clin Pharmacol.1994; 37:82-85.
Akerele JO and Akhamafe AO. Influence of co-administered metallic drugs on Ofloxacin Pharmacokinetic. J Antimicrob Chemother. 1991; 28:87-94.
Nix DE, Watson WA, Lener ME, Frost WR, George Krol, Harvey Goldstein MD, John Lettieri, Jerome J Schentag. Effect of Aluminum and Magnesium antacids and ranitidine on the absorption of Ciprofloxacin. Clin Pharmacol Ther. 1989; 46:700-705.
Ukpo GE, Owolabi MA, Imaga NO, Oribayo O, Ejiroghene AJ. Effect of Carica Papaya (Linn) aqueous leaf extract on pharmacokinetic profile of Ciprofloxacin in rabbit. Trop J Pharm Res. 2017; 16(1):127-134.
Lettieri JT, Rogge MC, Kaiser L, Echols RM, Heller AH.Pharmacokinetic profile of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother. 1992; 36:993-996.
Dasgupta A, Reyes MA, Risin SA. Interaction of white and pink grapefruit with acetaminophen (paracetamol) in vivo in mice. J Med food. 2008; 11(4):795-798
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
